Cansino Capital Stock from 2010 to 2024

688185 Stock   61.23  0.13  0.21%   
Cansino Biologics' Capital Stock is increasing over the years with slightly volatile fluctuation. Capital Stock is expected to dwindle to about 251.8 M. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals
 
Capital Stock  
First Reported
2010-12-31
Previous Quarter
284.6 M
Current Value
251.8 M
Quarterly Volatility
46.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cansino Biologics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cansino Biologics' main balance sheet or income statement drivers, such as Net Interest Income of 27.1 M, Interest Income of 105.1 M or Interest Expense of 67.4 M, as well as many indicators such as . Cansino financial statements analysis is a perfect complement when working with Cansino Biologics Valuation or Volatility modules.
  
This module can also supplement various Cansino Biologics Technical models . Check out the analysis of Cansino Biologics Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Cansino Stock

Cansino Biologics financial ratios help investors to determine whether Cansino Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cansino with respect to the benefits of owning Cansino Biologics security.